Cardiovascular Systems ROA 2006-2020 | CSII

Current and historical return on assets (ROA) values for Cardiovascular Systems (CSII) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Cardiovascular Systems ROA for the three months ending June 30, 2020 was -10.89%.
Cardiovascular Systems ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-06-30 $-0.03B $0.34B -10.79%
2020-03-31 $-0.01B $0.22B -5.00%
2019-12-31 $-0.01B $0.22B -3.21%
2019-09-30 $-0.00B $0.22B -1.87%
2019-06-30 $-0.00B $0.22B -0.48%
2019-03-31 $0.00B $0.21B 0.97%
2018-12-31 $0.00B $0.21B 0.50%
2018-09-30 $0.00B $0.20B 0.51%
2018-06-30 $0.00B $0.20B 1.03%
2018-03-31 $-0.00B $0.20B -0.52%
2017-12-31 $-0.00B $0.19B -1.58%
2017-09-30 $-0.00B $0.19B -1.10%
2017-06-30 $-0.00B $0.19B -1.18%
2017-03-31 $-0.01B $0.19B -5.11%
2016-12-31 $-0.03B $0.16B -19.86%
2016-09-30 $-0.05B $0.14B -31.25%
2016-06-30 $-0.06B $0.14B -37.33%
2016-03-31 $-0.06B $0.15B -38.16%
2015-12-31 $-0.05B $0.15B -28.96%
2015-09-30 $-0.04B $0.16B -21.93%
2015-06-30 $-0.03B $0.17B -18.51%
2015-03-31 $-0.03B $0.18B -18.78%
2014-12-31 $-0.03B $0.18B -18.08%
2014-09-30 $-0.04B $0.18B -20.27%
2014-06-30 $-0.04B $0.18B -22.40%
2014-03-31 $-0.03B $0.19B -23.66%
2013-12-31 $-0.03B $0.18B -24.58%
2013-09-30 $-0.03B $0.10B -29.89%
2013-06-30 $-0.02B $0.10B -30.67%
2013-03-31 $-0.02B $0.10B -31.54%
2012-12-31 $-0.02B $0.06B -34.78%
2012-09-30 $-0.02B $0.06B -32.00%
2012-06-30 $-0.02B $0.06B -31.92%
2012-03-31 $-0.01B $0.05B -28.43%
2011-12-31 $-0.01B $0.05B -25.13%
2011-09-30 $-0.01B $0.05B -21.74%
2011-06-30 $-0.01B $0.05B -22.47%
2011-03-31 $-0.01B $0.04B -27.59%
2010-12-31 $-0.02B $0.05B -35.42%
2010-09-30 $-0.02B $0.04B -41.71%
2010-06-30 $-0.02B $0.04B -40.17%
2010-03-31 $-0.03B $0.06B -38.81%
2009-12-31 $0.00B $0.06B 4.26%
2009-06-30 $0.00B $0.07B 4.00%
2009-03-31 $-0.01B $0.08B -34.38%
2008-06-30 $-0.06B $0.00B -119.15%
2008-03-31 $0.01B $0.08B 10.49%
2007-06-30 $0.03B $0.12B 31.09%
2007-03-31 $-0.02B $0.13B -25.60%
2006-09-30 $-0.04B $0.14B -48.56%
2006-06-30 $-0.04B $0.11B -98.82%
2006-03-31 $-0.04B $0.00B -256.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.097B $0.237B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.40
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.735B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.678B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 0.00
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
InMode (INMD) Israel $1.016B 25.62
OraSure Technologies (OSUR) United States $1.005B 0.00
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.600B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00